Unbound MEDLINE

Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases. Tropical medicine & international health : TM & IH [Trop Med Int Health] Journal article

 
TitlePentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases.
Author(s)Patel TA, Lockwood DN 
InstitutionHospital for Tropical Diseases, London, UK.
SourceTrop Med Int Health 2009 Jun 22.
AbstractWe report a retrospective and descriptive study of four immunocompromised patients (three with HIV-1 and one with idiopathic CD4+-lymphopenia) with relapsing visceral leishmaniasis seen at the Hospital for Tropical Diseases, London, in whom pentamidine was used as secondary prophylaxis to prevent relapse. Patients experienced between one and four relapses before commencing prophylaxis with subsequent relapse-free periods ranging from 5 to 98 months. Based on these observational data, we recommend large trials to investigate the efficacy of pentamidine over other agents in preventing relapse of VL in the immunocompromised patient.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19552658
  
Advertise on this site.